Related Experiment Video
Updated: May 21, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Specialised design for dementia.
1Maybourne Projects, 32 Larkfield Road, Richmond upon Thames, London TW1 2JX, UK. habellmartin@aol.com
Perspectives in Public Health
|June 26, 2012
Summary
Specialized dementia care environments improve health and behavior by addressing unique needs. Thoughtful design, focusing on space, light, and sensory elements, enhances well-being for individuals with dementia.
Area of Science:
- Gerontology and Environmental Psychology
- Specialized dementia care environments
- Impact of built environments on health and behavior
Background:
- Rising demand for elderly dementia care necessitates specialized environments.
- Traditional elderly care settings are inadequate for dementia patients.
- Focus on environmental design rather than care or medication.
Purpose of the Study:
- To explore the health and behavioral benefits of specialized dementia care environments.
- To highlight the inadequacies of traditional care settings.
- To advocate for a comprehensive environmental approach to dementia care.
Main Methods:
- Analysis of environmental factors in specialized dementia care buildings.
- Incorporation of therapeutic elements like memory trails and light therapy.
- Iterative design and adaptation of care home features based on feedback.
Main Results:
- Specialized environments require larger spaces and address security, light, sleep, sensory, and exercise needs.
- Internal environmental features (e.g., movement, memory trails, light therapy) offer therapeutic benefits.
- Strategic planning mitigates negative behaviors like agitation and confusion, promoting family involvement.
Conclusions:
- A coherent, comprehensive approach to the total environment is crucial for dementia care.
- Specialized environments are essential to meet the unique needs of individuals with dementia.
- Environmental design should be viewed as an integral tool in dementia care provision.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:29Intellectual Disability
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...